Effect of the Thiotepa Dose in the TBF Conditioning Regimen in Patients Undergoing Allogeneic Stem Cell Transplantation for Acute Myeloid Leukemia in Complete Remission: A Report From the EBMT Acute Leukemia Working Party

La Nasa, Giorgio;
2020-01-01

Abstract

Allogeneic stem cell transplantation is a potentially curative therapy for patients with acute myeloid leukemia (AML) after achieving complete remission (CR). The aim of this study is to evaluate the optimal dose of thiotepa, administered as part of the thiotepa-busulfan-fludarabine (TBF) conditioning regimen for allogeneic stem cell transplantation in adults with AML in CR.
2020
Inglese
20
5
296
304
9
WOS:000529823100009
2-s2.0-85079521024
32081702
/www.clinical-lymphoma-myeloma-leukemia.com/article/S2152-2650(20)30044-6/pdf
Esperti anonimi
internazionale
scientifica
Acute myloid leukemia; Complete remission; Overall survival (OS); Thiotepa-busulfan-fludarabine; Transplant outcomes
sì
El-Cheikh, Jean; Labopin, Myriam; Al-Chami, Farouk; Bazarbachi, Ali; Angelucci, Emanuele; Santarone, Stella; Bonifazi, Francesca; Carella, Angelo Mich ...espandi
1.1 Articolo in rivista
info:eu-repo/semantics/article
1 Contributo su Rivista::1.1 Articolo in rivista
262
15
reserved
Files in This Item:
File Size Format  
Effect of the Thiotepa Dose in the TBFConditioning Regimen in Patients UndergoingAllogeneic Stem Cell Transplantation for AcuteMyeloid Leukemia in Complete Remission.pdf

Solo gestori archivio

Type: versione post-print
Size 514.92 kB
Format Adobe PDF
& nbsp; View / Open   Request a copy
514.92 kB Adobe PDF & nbsp; View / Open   Request a copy

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

Questionnaire and social

Share on:
Impostazioni cookie